Membranous Nephropathy Latest Advances

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: March 20, 2026

Obinutuzumab for membranous nephropathy: a systematic review using pooled case-level extraction analysis.

Journal: Acta clinica Belgica

Published: March 19, 2026

Relapse of Membranous Nephropathy Following Adrenalectomy for Cushing Syndrome: A Case Report.

Journal: Internal medicine (Tokyo, Japan)

Published: March 18, 2026

Association between anti-rituximab antibodies and treatment efficacy of rituximab in membranous nephropathy.

Journal: Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association

Published: March 13, 2026

Membranous Nephropathy Latest Advances

Find the Latest Research About Membranous Nephropathy

Corrigendum "Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction MFSD to repair podocyte damage" [Biomed. & Pharmacother. 174 (2024) 116583].

Corrigendum "Activation of the IL-6/STAT3 pathway contributes to the pathogenesis of membranous nephropathy and is a target for Mahuang Fuzi and Shenzhuo Decoction MFSD to repair podocyte damage" [Biomed. & Pharmacother. 174 (2024) 116583].

Predictive value of CD44 in membranous nephropathy with focal segmental glomerular sclerosis lesions treated with calcineurin inhibitors.

Predictive value of CD44 in membranous nephropathy with focal segmental glomerular sclerosis lesions treated with calcineurin inhibitors.

Beyond Titers: Phospholipase A2 Receptor Epitope Complexity as a New Lens in Membranous Nephropathy.

Beyond Titers: Phospholipase A2 Receptor Epitope Complexity as a New Lens in Membranous Nephropathy.

Is Obinutuzumab the Answer to Primary Membranous Nephropathy Resistant to Rituximab?

Is Obinutuzumab the Answer to Primary Membranous Nephropathy Resistant to Rituximab?

Elevated serum CA-125 levels in a patient with membranous nephropathy and nephrotic syndrome in absence of malignancy.

Elevated serum CA-125 levels in a patient with membranous nephropathy and nephrotic syndrome in absence of malignancy.

Bactrim Efficacy in Preventing Infections in Glomerular Diseases Receiving Rituximab.

Bactrim Efficacy in Preventing Infections in Glomerular Diseases Receiving Rituximab.

Recurrent, Nonrecurrent, and De Novo Membranous Nephropathy After Kidney Transplantation: A Systematic Review and Meta-Analysis.

Recurrent, Nonrecurrent, and De Novo Membranous Nephropathy After Kidney Transplantation: A Systematic Review and Meta-Analysis.

A rare case of renal cancer with PLA2R-positive membranous nephropathy and AL amyloidosis: Insights into mechanisms and treatment.

A rare case of renal cancer with PLA2R-positive membranous nephropathy and AL amyloidosis: Insights into mechanisms and treatment.

Diabetes Mellitus Attenuates Response to Anti-CD20 Therapy in Primary Membranous Nephropathy Despite Equivalent B-Cell Depletion.

Diabetes Mellitus Attenuates Response to Anti-CD20 Therapy in Primary Membranous Nephropathy Despite Equivalent B-Cell Depletion.

Obinutuzumab for membranous nephropathy: a systematic review using pooled case-level extraction analysis.

Obinutuzumab for membranous nephropathy: a systematic review using pooled case-level extraction analysis.

Relapse of Membranous Nephropathy Following Adrenalectomy for Cushing Syndrome: A Case Report.

Relapse of Membranous Nephropathy Following Adrenalectomy for Cushing Syndrome: A Case Report.

Association between anti-rituximab antibodies and treatment efficacy of rituximab in membranous nephropathy.

Association between anti-rituximab antibodies and treatment efficacy of rituximab in membranous nephropathy.